Molecular Quality Control Market to Score Past US$ 132 million Valuation by 2027, increasing prevalence of Molecular Quality Control to boost growth of the Market

Molecular Quality Control Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Molecular Quality Control Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.

Global Molecular Quality Control Market – Insights

Molecular quality control is primarily used to track the effectiveness of in vitro nucleic acid testing procedures for viral load assays, healthcare-associated infections (HAIs), such as bloodstream infections, urinary tract infections, pneumonia, and other infections associated with sexually transmitted diseases. The primary goal of molecular quality control is to test molecular diagnostic products, find flaws, and report them to management.

Here is Request Sample Copy

Drivers:

The growth of the molecular quality control market is expected to be aided by key players expanding their businesses. For example, Bio-Rad Laboratories, Inc. announced its entry into the molecular diagnostic testing market in July 2016 with the introduction of Amplichek Quality Control, a new quality control system. This quality control is used in infectious disease molecular diagnostic research.

Bruker also announced the expansion of its MALDI Biotyper, IR Biotyper, and Fluorocycler XT product lines in April 2019. These drugs can be used for infectious disease microbial detection, infection prevention, and molecular diagnostics.

Furthermore, the growth of the molecular quality control market is expected to be fueled by increased collaboration activities. For example, Randox Laboratories announced a strategic alliance with Qnostics in February 2018 to expand the market for its Qnostics products.

Restraints:

The molecular quality control market is predicted to be hampered by inaccurate genetic testing. Invitae Corporation, for example, discovered a quality control problem with a hereditary cancer test in August 2017, which resulted in falsely negative results. This cancer test is performed on patients who have an unusual genetic mutation in the MSH2 gene that is linked to the Lynch syndrome.

Get Flat USD 2000 OFF

Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/2674

Reasons to Purchase this Report

• Current and future of global Lab-on-a-chip Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period.
• The latest developments, market shares, and strategies that are employed by the major market players.

Regional Analysis:

The global molecular quality control market is divided into Latin America, Europe, Asia Pacific, North America, Africa, and the Middle East.

Because of the growing launches of new control panels by key players, North America is expected to hold a dominant place in the global molecular quality control market. Microbiologics, Inc., for example, unveiled two new quality management panels in December 2018. Group A Streptococcus (GAS) and respiratory molecular assays. Multiplexed pellets, swabs that imitate patient sample handling, and room temperature storage are all included in these two tables.

Furthermore, due to increased collaboration activities by key players, Asia Pacific is expected to expand significantly in the global molecular quality control market. In June 2016, Thermo Fisher Scientific Inc. announced a collaboration with Sichuan University’s West China Hospital to improve the efficiency of pathological testing and diagnosis while also accelerating the production of precise pathological diagnosis.

Molecular Quality Control Market Taxonomy

By Product Type

• Independent Control
• Instrument Specific- Control
• DNA Sequencing and NGS (Next Generation Sequencing)
• PCR (Polymer Chain Reaction)
• Others

By Analyte Type

• Single Analyte
• Multi Analyte

By Application

• Oncology
• Genetic Testing
• Infectious Diseases
• Others

By End Users

• Clinical Laboratories
• Hospitals and Clinics
• Academic and Research Institutes
• IVD Manufacturers
• Contract Research Organizations
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837